Verrica Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: Verrica Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Verrica Pharmaceuticals Inc
Rating: 2.13866675
Author: Trendlyne DVM scores

about

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed...

5.60 0.05 (0.90%)

1335.90% Gain from 52W Low

41,112

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.2 / 100

Technically Bullish

74.4 / 100

1Yr Price target upside is 168%

2 analysts

Verrica Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Verrica Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed...

1335.90% Gain from 52W Low

SWOT Analysis

Verrica Pharmaceuticals Inc Live Price Chart